Vertex Pharmaceuticals Inc - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Vertex Pharmaceuticals Inc. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Vertex Pharmaceuticals Inc. The Group's principal activity is to discover, develop and market small molecule drugs for the treatment of serious diseases. These drugs used for the treatment of diseases like HIV infection, chronic hepatitis C virus infection, inflammatory and autoimmune disorders, cancer, bacterial infection, pain and other neurological diseases, independently and with collaborators. The Group's telaprevir drug candidate, is an oral hepatitis C protease inhibitor and new class of antiviral treatments in clinical development that target hepatitis C virus or HCV, infection, a life-threatening disease.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report